Thursday, November 29, 2018 11:59:04 AM
I held some through the spike on the belief that FDA approval was right around the corner. I was going to sell into that spike. I expected it before Q3 numbers. That would have allowed me to buy back in and get ready for the next spike on Innovation challenge or Dr. Scholl's.
There are many misses in there, take your pick. I don't claim to be good at this, nor did I ever say I had a crystal ball.
Of course luck plays a role in success with penny stocks, and I don't have much of that either.
What is obvious to anyone who is being honest is that buy and hold is not the best strategy here. And is likely not being followed by any but the most impressionable among us.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM